Trial | NCT00537875  Report issue

Official Title

Evaluation of the Effect of Zingiber Officinalis on Nausea and Vomiting in Patients Receiving Cisplatin Based Regimens

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    ginger ...

  • Study Participants

    36
The purpose of this study is to determine whether powdered ginger root (encapsulated ginger) is effective for reducing the frequency, duration and severity of both acute and delayed nausea and vomiting.
Study Started
Sep 30
2007
Primary Completion
Sep 30
2008
Study Completion
Sep 30
2009
Last Update
Oct 08
2015
Estimate

Dietary Supplement Ginger

Capsule, 1000 mg, BID, 3 days

Dietary Supplement Placebo

Capsule, 1000 mg, BID, 3 days

1 Active Comparator

2 Placebo Comparator

Criteria 

Inclusion Criteria:

Must be able to give written informed consent.
Have a diagnosis of cancer and currently receiving chemotherapy containing cisplatin (any dose).
Scheduled to receive antiemetics: granisetron (kytril), hydrocortisone.
Must be able to complete study questionnaires.
Must be able to swallow capsules.

Exclusion Criteria:

Have no clinical evidence of current or impending bowel obstruction.
Concurrent radiotherapy that is classified as high or intermediate risk of causing emesis.
Pregnant or lactating.
Patients taking therapeutic doses of coumadin (individuals on low-dose to maintain peripheral or central venous catheters are allowed), aspirin (individuals taking low-dose 80mg aspirin are allowed), or heparin.
Patients with a history of a bleeding disorder(s) in past 6 months and those experiencing thrombocytopenia.
No Results Posted